2-苄基-2,3,4,5-四氢-1H-吡啶并[4,3-b]吲哚 | 6208-43-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 2-苄基-2,3,4,5-四氢-1H-吡啶并[4,3-b]吲哚
• 英文名称: 2-benzyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
• 英文别名: 2-Benzyl-2,3,4,5-tetrahydro-1H-pyrido(4,3-b)indole；2-benzyl-1,3,4,5-tetrahydropyrido[4,3-b]indole
• CAS: 6208-43-1
• 化学式: C₁₈H₁₈N₂
• mdl: MFCD00427372
• 分子量: 262.354
• InChiKey: TWZCZLLZJDKWFN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  20
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  19
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-苄基-2,3,4,5-四氢-1H-吡啶并[4,3-b]吲哚 在 palladium 10% on activated carbon 、 氢气 作用下， 以 乙醇 、 水 为溶剂， 70.0 ℃ 、101.33 kPa 条件下， 反应 24.0h， 以93%的产率得到2,3,4,5-四氢-1H-吡啶并[4,3-b]吲哚
  参考文献：
  名称：

  Second-Generation Histone Deacetylase 6 Inhibitors Enhance the Immunosuppressive Effects of Foxp3+ T-Regulatory Cells

  摘要：

  Second-generation Tubastatin A analogues were synthesized and evaluated for their ability to inhibit selectively histone deacetylase 6 (HDAC6). Substitutions to the carboline cap group were well-tolerated with substitution at the 2-position of both beta- and gamma-carbolines being optimal for HDAC6 activity and selectivity. Some compounds in this series were determined to have subnanomolar activity at HDAC6 with more than 7000 fold selectivity for HDAC6 versus HDAC1. Selected compounds were then evaluated for their ability to augment the immunosuppressive effect of Foxp3+ regulatory T cells. All compounds tested were found to enhance the ability of regulatory T cells to inhibit the mitotic division of effector T cells both in vitro and in vivo, suggesting that further investigation into the use of these compounds for the treatment of autoimmune disorders is warranted.

  DOI：

  10.1021/jm200773h
• 作为产物：
  描述：

  N-(1-benzylpiperidin-4-ylidene)-N-(2-fluorophenyl)amine 在 lithium diisopropyl amide 作用下， 以 四氢呋喃 、 环己烷 为溶剂， 反应 5.0h， 以97%的产率得到2-苄基-2,3,4,5-四氢-1H-吡啶并[4,3-b]吲哚
  参考文献：
  名称：

  Synthesis of Substituted Indolesand Carbazoles from 2-Fluorophenyl Imines

  摘要：

  报道了从2-氟苯亚胺合成一系列吲哚和咔唑衍生物的方法。制备了2-氟苯胺-d4（13）并用于研究这种吲哚化的机制。2-氟苯烯胺酮17通过类似的吲哚化及原位烷基化反应得到了合成上有用的咔唑20。

  DOI：

  10.1055/s-2003-40880

文献信息

• New Route of BenzyneCyclization for Synthesis of 2,3,4,5-Tetrahydro-1H-pyrido[4,3-b]indole Derivatives Avoiding Highly Toxic Aryl Hydrazines
  作者：Lucia Kovacikova、Milan Stefek

  DOI：10.1002/jhet.2150

  日期：2014.9

  A new route for the regioselective synthesis of 2,3,4,5‐tetrahydro‐1H‐pyrido[4,3‐b]indole derivatives was developed based on cyclization of 3‐chlorophenylimine‐N‐alkyl‐4‐piperidones by “the complex bases” of NaNH2 or KNH2. The procedure was performed under variable reaction conditions in inert proton‐free solvents, such as THF, dioxane, 1,2‐dimethoxyethane, toluene, and xylene, at temperatures varying

  基于3-氯苯基亚胺-N-烷基-4-哌啶酮的环化作用，开发了一种新的区域选择性合成2,3,4,5-四氢-1H-吡啶并[4,3-b]吲哚衍生物的新途径。 NaNH 2或KNH 2的“复杂碱基” 。该程序是在可变的反应条件下，在惰性无质子溶剂（例如THF，二恶烷，1,2-二甲氧基乙烷，甲苯和二甲苯）中，在20°C至所用溶剂的沸点之间变化的温度下进行的。避免了在经典的Fischer吲哚合成中出现的有毒芳基肼中间体。
• [EN] ARYL CARBOXAMIDE DERIVATIVES AS SODIUM CHANNEL INHIBITORS FOR TREATMENT OF PAIN<br/>[FR] DÉRIVÉS D'ARYLCARBOXAMIDE EN TANT QU'INHIBITEURS DE CANAL SODIQUE POUR LE TRAITEMENT DE LA DOULEUR
  申请人：AMGEN INC

  公开号：WO2011103196A1

  公开（公告）日：2011-08-25

  The present invention provides compounds that are inhibitors of voltage-gated sodium channels (Nav), in particular Nav 1.7, and are therefore useful for the treatment of diseases treatable by inhibition of these channels, in particular, chronic pain disorders. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.

  本发明提供了一种抑制电压门控钠通道（Nav）的化合物，特别是Nav 1.7，因此适用于治疗通过抑制这些通道可治疗的疾病，特别是慢性疼痛疾病。还提供了含有这种化合物的药物组合物以及制备这种化合物的方法。
• Direct Synthesis of Indoles from Azoarenes and Ketones with Bis(neopentylglycolato)diboron Using 4,4′-Bipyridyl as an Organocatalyst
  作者：Luis C. Misal Castro、Ibrahim Sultan、Kohei Nishi、Hayato Tsurugi、Kazushi Mashima

  DOI：10.1021/acs.joc.0c02661

  日期：2021.2.19

  2-diarylhydrazines, which rearranged to the corresponding indoles via the Fischer indole mechanism. This organocatalytic system was applied to diverse alkyl cyclic ketones, dialkyl, and alkyl/aryl ketones, including heteroatoms. Methyl alkyl ketones gave the corresponding 2-methyl-3-substituted indoles in a regioselective manner. This protocol allowed us to expand the preparation of indoles having high compatibility

  通过在中性反应条件下，在催化量为4,4'-联吡啶的酮和双（新戊基糖基乙酸）二硼（B 2 nep 2）存在下还原偶氮芳烃，制备多官能化的吲哚衍生物。其中，4,4'-联吡啶为有机催化剂来激活B的B-B键2的棉结2和形成ñ，ñ '-diboryl -1,2- diarylhydrazines关键中间体。N，N'-二硼烷基-1,2-二芳基肼与酮的进一步反应得到N-乙烯基-1,2-二芳基肼，它们通过菲歇尔吲哚机理重排成相应的吲哚。该有机催化体系应用于各种烷基环酮，二烷基和烷基/芳基酮，包括杂原子。甲基烷基酮以区域选择性方式得到相应的2-甲基-3-取代的吲哚。该方案使我们能够扩展具有高相容性的吲哚的制备，所述吲哚不仅与给电子和吸电子基团而且与N-和O-保护官能团具有高相容性。
• Synthesis of 8-substituted tetrahydro-γ-carbolines
  作者：Alexandre Bridoux、Laurence Goossens、Raymond Houssin、Jean-Pierre Héanichart

  DOI：10.1002/jhet.5570430308

  日期：2006.5

  The Fischer reaction is applied to the synthesis of 8-substituted tetrahydro-γ-carbolines with electron-donating or electron-withdrawing groups, using catalytic or thermal methods. The reaction conditions must be varied according to the nature of the N 1 substituent of the piperidone. The best results are observed when a releasing group is present on the arylhydrazine and a benzyl substituent on the

  使用催化或热方法，将Fischer反应应用于具有供电子或吸电子基团的8-取代的四氢-γ-咔啉的合成。反应条件必须根据哌啶酮的N 1取代基的性质而变化。当芳基肼上的释放基团和哌啶酮的氮上的苄基取代基存在时，观察到最好的结果。在软酸性条件下观察到带有取代基的咔啉的形成；在其他情况下，反应在ended水平结束或没有发生。
• Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs
  申请人：Janssen Pharmaceutia, N.V.

  公开号：US06057325A1

  公开（公告）日：2000-05-02

  This invention concerns the compounds of formula ##STR1## the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein Alk is C.sub.1-6 alkanediyl; R.sup.1 is hydrogen, C.sub.1-6 alkyl, aryl or aryl C.sub.1-6 alkyl; R.sup.2, R.sup.3 and R.sup.4 are each independently selected from hydrogen, halo, hydroxy, nitro, cyano, C.sub.1-6 alkyl, C.sub.1-6 alkyloxy, trifluoromethyl, C.sub.1-6 alkylthio, mercapto, amino, mono- and di(C.sub.1-6 alkyl)amino, carboxyl, C.sub.1-6 alkyloxycarbonyl or C.sub.1-6 alkylcarbonyl; R.sup.5 is hydrogen, C.sub.1-6 alkyl, phenyl or phenylC.sub.1-6 alkyl; R.sup.6 is hydrogen, C.sub.1-6 alkyl, C.sub.1-6 alkyloxy, C.sub.1-6 alkylthio, or a radical of formula --NR.sup.8 R.sup.9, wherein R.sup.8 and R.sup.9 are each independently selected from hydrogen, C.sub.1-6 alkyl, phenyl or phenylC.sub.1-6 alkyl; R.sup.7 is hydrogen or C.sub.1-6 alkyl; or R.sup.6 and R.sup.7 taken together may form a bivalent radical of formula --R.sup.6 --R.sup.7 --; having central dopamine and serotonin antogonistic activity; their preparation, compositions containing them and their use as a medicine.

  这项发明涉及公式##STR1##的化合物，其药学上可接受的加合盐和立体化异构体形式，其中Alk为C.sub.1-6烷二基；R.sup.1为氢、C.sub.1-6烷基、芳基或芳基C.sub.1-6烷基；R.sup.2、R.sup.3和R.sup.4分别独立选择自氢、卤素、羟基、硝基、氰基、C.sub.1-6烷基、C.sub.1-6烷氧基、三氟甲基、C.sub.1-6烷硫基、巯基、氨基、单烷基和二(烷基)氨基、羧基、C.sub.1-6烷氧羰基或C.sub.1-6烷基羰基；R.sup.5为氢、C.sub.1-6烷基、苯基或苯基C.sub.1-6烷基；R.sup.6为氢、C.sub.1-6烷基、C.sub.1-6烷氧基、C.sub.1-6烷硫基，或者公式--NR.sup.8 R.sup.9的基团，其中R.sup.8和R.sup.9分别独立选择自氢、C.sub.1-6烷基、苯基或苯基C.sub.1-6烷基；R.sup.7为氢或C.sub.1-6烷基；或R.sup.6和R.sup.7一起可能形成公式--R.sup.6 --R.sup.7 --的双价基团；具有中枢多巴胺和5-羟色胺拮抗活性；它们的制备、含有它们的组合物以及它们作为药物的用途。